These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 11920411)

  • 1. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study.
    Ono M; Takamura E; Shinozaki K; Tsumura T; Hamano T; Yagi Y; Tsubota K
    Am J Ophthalmol; 2004 Jul; 138(1):6-17. PubMed ID: 15234277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer.
    Chambers MS; Posner M; Jones CU; Biel MA; Hodge KM; Vitti R; Armstrong I; Yen C; Weber RS
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1102-9. PubMed ID: 17379432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial.
    Fife RS; Chase WF; Dore RK; Wiesenhutter CW; Lockhart PB; Tindall E; Suen JY
    Arch Intern Med; 2002 Jun; 162(11):1293-300. PubMed ID: 12038948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.
    Leung KC; McMillan AS; Wong MC; Leung WK; Mok MY; Lau CS
    Clin Rheumatol; 2008 Apr; 27(4):429-36. PubMed ID: 17899308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia.
    Chambers MS; Jones CU; Biel MA; Weber RS; Hodge KM; Chen Y; Holland JM; Ship JA; Vitti R; Armstrong I; Garden AS; Haddad R
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1369-76. PubMed ID: 17855005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.
    Komai K; Shiozawa K; Tanaka Y; Yoshihara R; Tanaka C; Sakai H; Yamane T; Murata M; Tsumiyama K; Hashiramoto A; Shiozawa S
    Mod Rheumatol; 2009; 19(4):416-9. PubMed ID: 19452244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of cevimeline hydrochloride in the treatment of dry mouth in patients with Sjögren's syndrome].
    Ogawa N; Shimoyama K; Karasawa H; Fukushima T; Masaki Y; Wano Y; Hirose Y; Sugai S
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Oct; 27(5):330-7. PubMed ID: 15559322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cevimeline.
    Weber J; Keating GM
    Drugs; 2008; 68(12):1691-8. PubMed ID: 18681491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.
    Meijer JM; Meiners PM; Vissink A; Spijkervet FK; Abdulahad W; Kamminga N; Brouwer E; Kallenberg CG; Bootsma H
    Arthritis Rheum; 2010 Apr; 62(4):960-8. PubMed ID: 20131246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
    Sankar V; Brennan MT; Kok MR; Leakan RA; Smith JA; Manny J; Baum BJ; Pillemer SR
    Arthritis Rheum; 2004 Jul; 50(7):2240-5. PubMed ID: 15248223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new medication for treatment of dry mouth in Sjögren's syndrome.
    al-Hashimi I; Taylor SE
    Tex Dent J; 2001 Apr; 118(3):262-6. PubMed ID: 11404944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
    Fox RI; Dixon R; Guarrasi V; Krubel S
    Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial.
    Alves MB; Motta AC; Messina WC; Migliari DA
    Quintessence Int; 2004 May; 35(5):392-6. PubMed ID: 15130080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cevimeline on salivary components in patients with Sjögren syndrome.
    Suzuki K; Matsumoto M; Nakashima M; Takada K; Nakanishi T; Okada M; Ohsuzu F
    Pharmacology; 2005 May; 74(2):100-5. PubMed ID: 15722648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
    Mariette X; Ravaud P; Steinfeld S; Baron G; Goetz J; Hachulla E; Combe B; Puéchal X; Pennec Y; Sauvezie B; Perdriger A; Hayem G; Janin A; Sibilia J
    Arthritis Rheum; 2004 Apr; 50(4):1270-6. PubMed ID: 15077311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
    Fox RI; Konttinen Y; Fisher A
    Clin Immunol; 2001 Dec; 101(3):249-63. PubMed ID: 11726216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cevimeline gargle for the treatment of xerostomia in patients with Sjögren's syndrome.
    Takagi Y; Kimura Y; Nakamura T
    Ann Rheum Dis; 2004 Jun; 63(6):749. PubMed ID: 15140789
    [No Abstract]   [Full Text] [Related]  

  • 20. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome.
    Pillemer SR; Brennan MT; Sankar V; Leakan RA; Smith JA; Grisius M; Ligier S; Radfar L; Kok MR; Kingman A; Fox PC
    Arthritis Rheum; 2004 Aug; 51(4):601-4. PubMed ID: 15334433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.